Key result
Hospitalist comanagement linked to ~50% lower in-hospital mortality in vascular surgery patients.
Why the study?
Hospitalized vascular surgery patients have multiple severe comorbidities and high perioperative cardiac risk, but there is little evidence on the effects of a hospitalist-vascular surgery comanagement model on clinical outcomes.
Does a hospitalist-vascular surgery comanagement model reduce complications and mortality in high-risk vascular surgery patients?
Observational
Does a hospitalist-vascular surgery comanagement model reduce complications and mortality in high-risk vascular surgery patients?
Absolute Event Rate: 1% vs 2.01%
p-value: p=0.049
A hospitalist-vascular surgery comanagement model significantly reduced in-hospital mortality, complications, and pain scores among high-risk vascular surgery patients.
Comanagement was associated with fewer complications and lower mortality in high-risk vascular surgery patients; leaves open need for prospective trials before practice change.
OBJECTIVES: Hospitalized vascular surgery patients have multiple severe comorbidities, poor functional status, and high perioperative cardiac risk. Thus they may be ideal patients for a collaborative care model. However, there is little evidence for a comanagement model on clinical outcomes. METHODS: The two-year pre-post study consisted of a comanagement model where a hospitalist actively participated in the medical care of American Society of Anesthesiologist Physical Status Classification scale 3 or 4 vascular surgery patients. Outcomes were in-hospital mortality, length of stay, 30-day readmission rate, pain scores, and patient safety metrics. RESULTS: With comanagement, patient complications decreased from 3.5 to 2.2 events per 1000 patients. (p = 0.045). Mortality decreased from 2.01% to 1.00% (p = 0.049), corresponding to a decrease in the risk-adjusted observed to expected mortality rate ratio from 1.22 to 0.53 (p = 0.01). Patient reported pain scores improved; more patients in the comanagement cohort expressed no pain (72% vs 82.8%; p = 0.01) and there were reductions in reports of mild and moderate pain. There was no significant difference in the risk-adjusted length of stay (observed to expected ratio 0.83 to 0.88 for the pre-intervention and comanagement groups, respectively, p = 0.48). The 30-day readmission rate was unchanged (21.9 vs 20.6% p = 0.44). Patients in the intervention period were more clinically complex, as evidenced by the greater case mix index (2.21 vs 2.44). CONCLUSIONS: After two years of implementation, our comanagement service reduced complications, mortality, and pain scores among high-risk vascular surgery patients.
No takes yet. Share an insight, caveat, or question.
Iberti et al. (2016) conducted an observational in Vascular surgery. Hospitalist-vascular surgery comanagement vs. Pre-intervention care was evaluated on In-hospital mortality (p=0.049). Hospitalist-vascular surgery comanagement reduced in-hospital mortality from 2.01% to 1.00% (p=0.049) and complications from 3.5 to 2.2 events per 1000 patients (p=0.045).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: